CG Oncology, Inc.
CGONNASDAQHealthcareBiotechnology
As of Oct 23, 2026 close
- Market cap
- $5.44B
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $35.80$80.97
- Volume (live)
- -
- Avg. volume (3M)
- 1.04M
CG Oncology (CGON) Stock Price & Financial Analysis
CG Oncology Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $59.86 - $62.36 |
|---|---|
| 52-Week High | $80.97 |
| 52-Week Low | $35.80 |
| Open | $62.36 |
| Volume (last close) | 1.07M |
| Average Volume (3M) | 1.04M |
| Revenue (TTM) | 6.23M |
|---|---|
| Net Income (TTM) | -224.38M |
| Free Cash Flow (TTM) | -179.34M |
| EPS (TTM) | −$2.75 |
| Profit Margin | -3602.68% |
| Operating Margin | -4056.18% |
| Return on Equity (ROE) | -21.80% |
| Debt to Equity | 0.00 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Market Cap | 5.44B |
|---|---|
| Shares Outstanding | 88.20M |
| Price to Sales (P/S) | 873.93 |
| Price to Book (P/B) | 5.29 |
| EV/EBITDA | -22.61 |
| 50-Day MA | $71.68 |
|---|---|
| 200-Day MA | $65.29 |
| 1-Year Change | +49.07% |
Source: Market prices and company fundamentals. Data as of Oct 23, 2026. Data sources and methodology
CG Oncology at a Glance
As of the Oct 23, 2026 close, CG Oncology (CGON) has a market capitalization of $5.44B. The stock trades at 873.9× sales. Over the trailing twelve months it lost $224.38M on revenue of $6.23M and burned $179.34M of free cash flow. Revenue grew 1030.3% year over year.
As of its latest reported balance sheet, it holds $19.64M in cash and securities against $3.98M of debt, a net cash position of $15.65M.
CG Oncology does not currently pay a dividend.
The share price is up 49.1% over the past year. At $61.71 (the Oct 23, 2026 close) it sits within its 52-week range of $35.80 to $80.97, below its 200-day moving average of $65.29.
Based on 12 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $92.30, 49.6% above the Oct 23, 2026 close.
Frequently Asked Questions About CG Oncology
What is the current stock price for CGON?
As of the Oct 23, 2026 close, CGON stock trades at $61.71. The 52-week range is $35.80–$80.97, with a day range of $59.86–$62.36.
What is the P/E ratio for CGON?
The P/E ratio (Price-to-Earnings) for CGON is shown in the Key Statistics section. This valuation metric helps compare CG Oncology, Inc. to industry peers.
Does CGON pay dividends?
CG Oncology does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for CGON?
Based on ratings from 12 professional analysts over the last 90 days, the consensus for CGON is Buy. The average 12-month price target is $92.30, a 49.6% upside from the Oct 23, 2026 close of $61.71.
What is the market cap of CGON?
As of the Oct 23, 2026 close, CG Oncology's market capitalization is $5.44B, classifying it as a mid-cap company. CG Oncology operates in the Healthcare sector within the Biotechnology industry.